EDGAR Filing Documents for 0001615774-15-003667

Form 8-K - Current report:

SEC Accession No. 0001615774-15-003667

Filing Date

2015-12-17

Accepted

2015-12-17 16:46:11

Documents

Period of Report

2015-12-15

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	s102370_8k.htm	8-K	26425
2	EXHIBIT 10.1	s102370_ex10-1.htm	EX-10.1	44255
3	EXHIBIT 10.2	s102370_ex10-2.htm	EX-10.2	50011
4	EXHIBIT 10.3	s102370_ex10-3.htm	EX-10.3	37243
5	EXHIBIT 10.4	s102370_ex10-4.htm	EX-10.4	43212
	Complete submission text file	0001615774-15-003667.txt		202617

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158

Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300

NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)